Considerations for Waiver Requests for pH Adjusters in Generic Drug Products Intended for Parenteral, Ophthalmic, or Otic Use: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 17, 2025
November 17, 2025
40969c10-8c6c-42cb-b3eb-03f03eb9fa38
Related Documents
Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs
Guidance DocumentMarch 17, 2026Center for Drug Evaluation and Research
Assessing the Effects of Food on Drugs in INDs and NDAs – Clinical Pharmacology Considerations
Guidance DocumentMay 20, 2026Center for Drug Evaluation and Research
Certain Postapproval Requirements and Resources for ANDAs
Guidance DocumentJune 4, 2026Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.